Reduction of seizures with low-dose clonazepam in children with epilepsy

Pediatric Neurology

Volumn 28, Issue 1, 2003, Pages 48-52

  Dahlin, Maria G ^a   Åmark, Per E ^a   Nergårdh, Arne R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; LAMOTRIGINE; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; EPILEPSY; FEMALE; HOSPITAL PERSONNEL; HOSPITALIZATION; HUMAN; INFANT; INHIBITION KINETICS; LOW DRUG DOSE; MALE; OPEN STUDY; PRIORITY JOURNAL; RECORDING; SEIZURE;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CLONAZEPAM; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; FEMALE; HUMANS; INFANT; MALE; TREATMENT OUTCOME;

EID: 0037235456     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(02)00468-X     Document Type: Article

References (22)

1. Browne TR. Drug therapy. Clonazepam. N Engl J Med 1978:812-6.
2. Tassinari C.A., Michelucci R., Riguzzi P., et al. The use of diazepam and clonazepam in epilepsy. Epilepsia. 39:(Suppl 1):1998;S7-14.
3. Ko D.Y., Rho J.M., De Giorgio C.M., Sato S. Benzodiazepines. Engel J. Jr, Pedley T.A. Epilepsy A comprehensive textbook. 1998;1475-1490 Lippincott-Raven Publishers, Philadelphia.
4. Dreifuss F.E., Penry J.K., Rose S.W., Kupferberg H.J., Dyken P., Sato S. Serum clonazepam concentrations in children with absence seizures. Neurology. 25:1975;255-258.
5. Nanda R., Keogh H.D., Lambie D., Johnson R.H., Melville I.D., Morrice G.D. The effects of clonazepam upon epilepsy control and plasma levels of other anticonvulsants. Janz D. Epileptology Proceedings of the Seventh International Symposium on Epilepsy. 1976;145-151 Thieme, Stuttgart.
6. Mikkelsen B., Birket-Smith E., Brandt S., et al. Clonazepam in the treatment of epilepsy A controlled clinical trial in simple absences, bilateral massive myoclonus and atonic seizures. Arch Neurol. 33:1976;322-325.
7. Bensch J., Blennow G., Ferngren H., et al. A double-blind study of clonazepam in the treatment of therapy-resistant epilepsy in children. Dev Med Child Neurol. 19:1977;335-342.
8. Mikkelsen B., Berggreen P., Joensen P., Kristensen O., Kohler O., Mikkelsen B.O. Clonazepam (Rivotril) and carbamazepine (Tegretol) in psychomotor epilepsy A randomized multicenter trial. Epilepsia. 22:1981;415-420.
9. Naito H., Wachi M., Nishida M. Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics. Acta Neurol Scand. 76:1987;58-63.
10. Mc Namara J.O. Drugs effective in the therapy of the epilepsies. Hardman J.G., Limbird L.E. Goodman & Gilman's The pharmacological basis of therapeutics. 1996;461-486 McGraw-Hill, New York.
11. Aicardi J. Medical treatment. Aicardi J. Epilepsy in children. 2nd ed:1992;402-428 Raven Press, New York.
12. Dahlin M., Knutsson E., Amark P., Nergardh A. Reduction of epileptiform activity in response to low-dose clonazepam in children with epilepsy a randomized, double-blind study. Epilepsia. 41:2000;308-315.
13. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 22:1981;489-501.
14. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
15. Rovei V., Sanjuan M. Simple and specific high performance liquid chromatographic method for the routine monitoring of clonazepam in plasma. Ther Drug Monit. 2:1980;283-287.
16. Boukhabza A., Lugnier A.A., Kintz P., Mangin P., Chaumont A.J. Simple and sensitive method for monitoring clonazepam in human plasma and urine by high performance liquid chromatography. J Chromatogr. 529:1990;210-216.
17. Painter P.C., Cope J.Y., Smith J.L. Reference information for the clinical laboratory. Burtis C.A., Ashwood E.R. Tietz textbook of clinical chemistry. 1999;1788-1846 WB Saunders Company, Philadelphia.
18. Eadie M.J. Neurological diseases. Speight T.M., Holford N.G.H. Avery's drug treatment. 1997;1347-1394 Adis International, Auckland.
19. Haslem R.H.A. The nervous system. Behrman R.E., Kliegman R.M., Jenson H.B. Nelson textbook of pediatrics. 2000;1793-1866 WB Saunders Company, Philadelphia.
20. Rey E., Tréluyer J., Pons G. Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Clin Pharmacokinet. 36:1999;409-424.
21. Greenblatt D.J., Miller L.G., Shader R.I. Clonazepam pharmacokinetics, brain uptake, and receptor interactions. J Clin Psychiatry. 48:(Suppl 10):1987;4-9.
22. Montplaisir J., Laverdière M., Saint-Hilaire J.M. Sleep and epilepsy. Gotman J., Ives J.R., Gloor P. Long-term monitoring in epilepsy (EEG Suppl. No. 37). 1985;215-239 Elsevier Science Publishers, Amsterdam.